Pneumococcus has been shown to bind to epithelial cells of the nasopha
rynx and lung, and to endothelial cells of the peripheral vasculature.
To characterize bacterial elements required for attachment to these c
ell types, a library of genetically altered pneumococci with defects i
n exported proteins was screened for the loss of attachment to glycoco
njugates representative of the nasopharyngeal cell receptor, type II l
ung cells (LC) and human endothelial cells (EC). A mutant was identifi
ed which showed a greater than 70% loss in the ability to attach to al
l cell types. This mutant also showed decreased adherence to the glyco
conjugates containing the terminal sugar residues GalNAc beta 1-3Gal,
GalNAc beta 1-4Gal and the carbohydrate GlcNAc, which are proposed com
ponents of the pneumococcal receptors specific to the surfaces of LC a
nd EC. Analysis of the locus altered in this mutant revealed a gene, s
pxB, that encodes a member of the family of bacterial pyruvate oxidase
s which decarboxylates pyruvate to acetyl phosphate plus H2O2 and CO2.
This mutant produced decreased concentrations of H2O2 and failed to g
row aerobically in a chemically defined medium, unless supplemented wi
th acetate which presumably restores acetyl phosphate levels by the ac
tion of acetate kinase, further suggesting that spxB encodes a pyruvat
e oxidase. The addition of acetate to the growth medium restored the a
dherence properties of the mutant indicating a link between the enzyme
and the expression of bacterial adhesins. A defect in spxB correspond
ed to impaired virulence of the mutant in vivo. Compared to the parent
strain, an spxB mutant showed reduced virulence in animal models for
nasopharyngeal colonization, pneumonia, and sepsis. We propose that a
mutation in spxB leads to down-regulation of the multiple adhesive pro
perties of pneumococcus which, in turn, may correlate to diminished vi
rulence in vivo.